Concepedia

Brian T. Kalet

BT

7

Publications

265

Citations

7

H-Index

2004

Active since

Affiliations

University of Colorado Boulder(Current)

University of Colorado Cancer Center

University of Colorado Denver

Brian T. Kalet is an author at University of Colorado Boulder specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryMedicinal ChemistryBiochemistryTumor BiologyChemical BiologyNatural SciencesRadiation OncologyBiomolecular Engineering

Publications per year

2004–2013

7

Publications

7

Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin.

David J. Burkhart, Brian T. Kalet, Michael P. Coleman et al. · PubMed · 2004 · 69 citations

Molecular Pharmacology, Medicinal Chemistry, Drug Conjugates +14

Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin

David J. Burkhart, Brian T. Kalet, Michael P. Coleman et al. · Molecular Cancer Therapeutics · 2004 · 64 citations · Full text

Drug Conjugates, Peptide Therapeutics, Immunotherapeutics +16

Design, Synthesis, and Preliminary Evaluation of Doxazolidine Carbamates as Prodrugs Activated by Carboxylesterases

David J. Burkhart, Benjamin L. Barthel, Glen C. Post et al. · Journal of Medicinal Chemistry · 2006 · 48 citations · Full text

Combinatorial Chemistry, Selective Hydrolysis, Pharmaceutical Chemistry +20

Doxazolidine Induction of Apoptosis by a Topoisomerase II Independent Mechanism

Brian T. Kalet, Meagan McBryde, Joaquı́n M. Espinosa et al. · Journal of Medicinal Chemistry · 2007 · 24 citations · Full text

Transcription Factor Ets1 Cooperates with Estrogen Receptor α to Stimulate Estradiol-Dependent Growth in Breast Cancer Cells and Tumors

Brian T. Kalet, Sara R. Anglin, Anne V. Handschy et al. · PLoS ONE · 2013 · 23 citations · Full text

Rows per page

1–5 of 7